Pathology of chronic obstructive pulmonary disease

Pathology and Oncology Research

Volumn 12, Issue 1, 2006, Pages 52-60

  Szilasi, Mária ^a   Dolinay, Tamás ^a   Nemes, Zoltán ^a   Strausz, János ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

Chronic bronchitis; Emphysema; Inflammation; Obstructive bronchiolitis

Indexed keywords

CD4 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS LIGAND; FIBROBLAST GROWTH FACTOR; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BRONCHIOLITIS; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE EXACERBATION; EMPHYSEMA; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; LUNG FUNCTION; MORAXELLA CATARRHALIS; MUSCLE ATROPHY; PNEUMONIA; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; STREPTOCOCCUS PNEUMONIAE;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 33646005787     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02893433     Document Type: Conference Paper

References (67)

1. Aoshiba K, Yokohori N, Nagai A: Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol 28: 555-562, 2003
2. Böszörményi Nagy G: Chronic obstructive pulmonary disease. In: Epidemiology and Functional Data in Pulmonology Institutions in year 2004 [book in Hungarian] (Eds: Jonás J, Fodor K, Türgyei M and Nyári L), Országos Korányi TBC és Pulmonológiai Intézet, 2005, pp. 50-56
3. Chodosh S: Treatment of acute exacerbations of chronic bronchitis: state of the art. Am J Med 91: 87S, 1991
4. Daheshia M: Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD). Curr Med Res Opin 21: 587-593, 2005
5. de Dodoy I, Donahoe M, Calhoun WJ, et al: Elevated TNF-alpha production by peripheral blood monocytes of weight-loosing COPD patients. Am J Respir Crit Care Med 153: 633-637, 1996
6. Deshmukh HS, Case LM, Wesselkamper SC: Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med 171: 305-314, 2005
7. Di Stefano A, Capelli A, Lusuardi M, et al: Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 158: 1277-1285, 1998
8. Drost EM, Skwarski J, Sauleda J, et al: Oxidative stress and airway inflammation in severe extracerbations of COPD. Thorax 60: 293-300, 2005
9. Enelow RI, Mohammed AZ, Stoler MH, et al: Structural and functional consequences of alveolar cell recognition by CD8+ T lymphocytes in experimental lung disease. J Clin Invest 102: 1653-1661, 1998
10. Fletcher C, Peto R, Tinker C, et al: The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, Oxford, England: 93, 1976
11. Giaid A, Yanagisawa M, Langleben D, et al: Expression of endothelin-1 in lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739, 1993
12. Gump DW, Philips CA, Forsyth BR: Role of infection in chronic bronchitis. Am Rev Respir Dis 113: 465, 1976
13. Hansel TT, Barnes PJ, Celli BR: Introduction: definitions, burden and causation. In: An Atlas of Chronic Obstructive Pulmonary Disease (Eds: Hansel TT, Barnes PJ and Celli BR), The Parthenon Publishing Group, 2004, pp. 1-19
14. Haraguchi M, Shimura S, Shirato K: Morphometric analysis of bronchial cartilage in chronic obstructive pulmonary disease and bronchial asthma. Am J Respir Crit Care Med 159: 1005-1013, 1999
15. Hogg JC, Chu F, Utokaparch S, et al: The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653, 2004
16. Hogg JC, Macklem PT, Thurlbeck WM: Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278: 1355-1360, 1968
17. Hubbard RC, Fells G, Gadek J, et al: Neutrophil accumulation in the lung in alpha-1 antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 88: 891-897, 1991
18. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 164: S28-S38, 2001
19. Kasahara Y, Tuder RM, Cool CD, et al: Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163: 737-744, 2001
20. Kasahara Y, Tunder RM, Taraseviciene-Stewart L, et al: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 106: 1311-1319, 2000
21. Keatings VM, Collins PD, Scott DM, et al: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 153: 530-534, 1996
22. Kim WD, Eidelman DH, Izquierdo JL, et al: Centrilobular and panlobular emphysema in smokers. Two distinct morphological and functional entities. Am Rev Respir Dis 144: 1385-1390, 1991
23. Kranenburg AR, de Boer WI, Alagappan VK, et al: Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 60: 106-113, 2005
24. Ladner KJ, Caligiuri MA, Guttridge DC: TNF regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 24278: 2294-2303, 2003
25. Lams BE, Sousa AR, Rees PJ, Lee TH: Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 1518-1523, 1998
26. Lams BE, Sousa AR, Rees PJ, Lee TH: Subepithelial immunopathology of the large airways in smokers with and without chronic obstructive pulmonary disease. Eur Respir J 15: 512-516, 2000
27. Langen RC, Schols AM, Kelders MC, et al: Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. Faseb J 15: 1169-1180, 2001
28. Lees AW, McNaught W: Bacteriology of lower respiratory tract secretions, sputum and upper respiratory tract secretions in "normals" and chronic bronchitis. Lancet 2: 1112, 1959
29. Li YP, Schwartz RJ, Waddell ID, et al: Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappa B activation in response to tumor necrosis factor alpha. Faseb J 12:871-880, 1998
30. Liu AN, Mohammed AZ, Rice WR, et al: Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha. Am J Respir Cell Mol Biol 20: 849-858, 1999
31. Matsuba K, Thurlbeck WM: The number and dimension of small airways in emphysematous lungs. Am J Pathol 67: 265-275, 1972
32. McCrory DC, Brown C, Gelfand SE, et al: Management of acute exacerbation of COPD: a summary and appraisal of published evidence. Chest 119: 1190-1209, 2001
33. Medical Research Council: Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet i: 775-779, 1965
34. Miotto D, Hollenberg MD, Bunnett NW, et al: Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers. Thorax 57: 146-151, 2002
35. NHLBI/WHO workshop report: Global initiative for chronic obstructive lung disease. National Heart, Lung and Blood Institution Publication Nr. 2701, 2001
36. Niewoehner DE, Klienerman J, Rice D: Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 291: 755-758, 1974
37. Ning W, Li CJ, Kaminski N, et al: Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 101: 14895-14900, 2004
38. O'Shaughnessy TC, Ansari TW, Barnes NC, et al: Reticular basement membrane thickness in moderately severe asthma and smokers' chronic bronchitis with or without airflow obstruction [abstract]. Am J Respir Crit Care Med 153: A879, 1996
39. Oudijk EJ, Lammers JW, Koenderman L: Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl 46: 5s-13s, 2003
40. Payne D, Roger AV, Jaffe A, et al: Reticular basement membrane thickness in children with severe asthma [abstract]. Arch Dis Child 82: A42, 2000
41. Peinado VI, Barbera JA, Abate P, et al: Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 1605-1611, 1999
42. Qiu Y, Zhu J, Bandi V et al: Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168: 968-975, 2003
43. Reid L: Measurement of bronchial mucous gland layer: a diagnostic yardstick in chronic bronchitis. Thorax 6: 132-141, 1960
44. Reid L: Pathology of chronic bronchitis. Lancet 266: 274-278, 1954
45. Richter A, O'Donnell RA, Powell RM, et al: Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol 27: 85-90, 2002
46. Rohde C, Wiethege A, Borg I: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 58: 37, 2003
47. Rooks SW, Bayley DL, Hill SL, et al: Bronchial inflammation in acute bacterial exacerbation of chronic bronchitis: the role of leukotriene B4. Eur Respir J 15: 274-280, 2000
48. Saetta M: Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: S17-S20, 1999
49. Saetta M, Baraldo S, Corbino L, et al: CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 711-717, 1999
50. Saetta M, Di Stefano A, Maestrelli P, et al: Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 147: 301-306, 1993
51. Saetta M, Di Stefano A, Maestrelli P, et al: Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 150: 1646-1652, 1994
52. Saetta M, Di Stefano A, Turato G, et al: CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 822-826, 1998
53. Saetta M, Turato G, Baraldo S, et al: Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 161: 1016-1021, 2000
54. Saetta M, Turato G, Maestrelli P, et al: Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: 1304-1309, 2001
55. Saint S, Bent S, Vittinghoff E, et al: Antibiotics in chronic obstructive pulmonary disease exacerbation: A meta-analysis. JAMA 273: 957-960, 1995
56. Santos S, Peinado VI, Ramirez J, et al: Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1250-1256, 2003
57. Segura-Valdez L, Pardo A, Gaxiola M: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117: 684-694, 2000
58. Seti S, Evans N, Grant BJ, et al: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347: 465-473, 2002
59. Snider GL: Chronic obstructive pulmonary disease: a continuing challenge. Am Rev Respir Dis 133: 942-944, 1986
60. Takeyama K, Dabbagh K, Lee HM, et al: Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A 96: 3081-3086, 1999
61. ten Hacken NH, Postma DS, Timens W: Are asthma and chronic obstructive pulmonary disease different diseases?-Con. Monaldi Arch Chest Dis 54: 551-558, 1999
62. Tuder RM, Zhen L, Cho CY, et al: Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 29: 88-97, 2003
63. Vestbo J, Lange P: Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 66: 329-332, 2002
64. Vestbo J, Prescott E, Lange P: Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Am J Respir Crit Care Med 153: 1530-1535, 1996
65. Vlahovic G, Russell ML, Mercer RR, et al: Cellular and connective tissue changes in alveolar septal wall in emphysema. Am J Respir Crit Care Med 160: 2086-2092, 1999
66. Vliagoftis H, Schwingshackl A, Milne CD, et al: Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 106: 537-545, 2000
67. Zheng T, Kang MJ, Crothers K, et al: Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 174: 8106-8115, 2005